SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dave O. who wrote (17)9/3/1996 11:35:00 AM
From: DeadHead   of 1172
 
According to reports in the other CMTR thread, their HIV test is expected to be approved this month or next. Though approval of the test might move the stock on hype, don't expect it to add much to their bottom line in the near future. Their best bet at profitability in the near term is their H. pylori test.

ChemTrak's HIV test is one in which the sample is taken in the home, but must be mailed to ChemTrak for analysis. It's not a quick test, like the ones offered by SALV and Tinity. But, for various social/political reasons, the FDA will probably not approve a home-based quick test for HIV anytime in the near future. That leaves the home HIV test that was already approved for J&J (and then spun off to another company when they canned the developer) and ChemTrak's. I don't know of any other tests in the pipeline that are awaiting for approval anytime in the near future.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News